GLF
BMY icon

Groupe la Francaise’s Bristol-Myers Squibb BMY Stock Holding History

Groupe la Francaise’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.61K Hold
89
– – ﹤0.01% 437
2025
Q4 		$4.05K Sell
89
-1,720
-95% -$82.7K ﹤0.01% 442
2025
Q3 		$80.9K Sell
1,809
-250
-12% -$11.7K ﹤0.01% 463
2025
Q2 		$94.9K Buy
2,059
+1,970
+2,213% +$96.7K ﹤0.01% 395
2025
Q1 		$4.81K Hold
89
– – ﹤0.01% 427
2024
Q4 		$3K Buy
+89
New +$4.97K ﹤0.01% 325

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Groupe la Francaise's BMY Position: Q1 2026 in Review

Groupe la Francaise held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 89 shares worth $4.61K. The position accounts for ﹤0.01% of the portfolio, ranked #437.

Groupe la Francaise first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $94.9K in Q2 2025. 2,532 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Groupe la Francaise held 89 shares of Bristol-Myers Squibb worth $4.61K as of Q1 2026.
  • Groupe la Francaise left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up ﹤0.01% of Groupe la Francaise's portfolio in Q1 2026, its #437 holding.
  • Groupe la Francaise first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Groupe la Francaise's Bristol-Myers Squibb position peaked at $94.9K in Q2 2025.
  • 2,532 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.